NFYA transcriptionally activates GPX4 inhibiting ferroptosis in colorectal cancer
- 13 January 2026
- journal article
- Published by Elsevier in Tissue and Cell
- Vol. 99, 103325
Abstract
No abstract availableKeywords
Funding Information
- Harbin Medical University (HYDSYYXQW2023003)
- Key Research and Development Program of Heilongjiang (2024ZX12C11)
This publication has 30 references indexed in Scilit:
- Astragali radix - Curcumae rhizoma herb pair suppresses hepatocellular carcinoma through EGFR/AKT/mTOR pathway and induces lipid peroxidation-related ferroptosis via HIF-1α/HO-1/GPX4 axisJournal of Ethnopharmacology, 2025
- Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosisCellular Signalling, 2024
- The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancerCancer Letters, 2023
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applicationsCell, 2022
- Drug resistance in colorectal cancer: An epigenetic overviewBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Role of GPX4 in ferroptosis and its pharmacological implicationFree Radical Biology and Medicine, 2019
- NF-Y in cancer: Impact on cell transformation of a gene essential for proliferationBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2017
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012